CCTV supports GPD in Shenzhen: 1.5 billion yuan saved a year by deleting "fake innovation" varieties

Recently, a news broadcast made Shenzhen drug procurement mode officially recognized In the past three years, Shenzhen exploration Pharmaceutical Group has achieved remarkable results in reducing drug prices, ensuring supply and optimizing services, according to news reports Up to now, 14 cities in Guangdong Province have participated in the procurement of Shenzhen Pharmaceutical Group Shenzhen City, on the other hand, has made full use of big data to grasp the national sales price of the varieties in the purchase catalogue In combination with the drug use in Shenzhen City and in direct negotiations with pharmaceutical factories, the decline of commonly used drugs for some major and chronic diseases has exceeded 50%, the decline of tumor drugs has reached 70%, and the comprehensive decline has reached 21.99% At the same time of reducing the drug cost, Shenzhen also "slimmed down" the drug purchase catalogue, eliminated a large number of "fake innovation" varieties such as strange dosage forms and specifications, and compressed 40 dosage forms originally purchased on the provincial platform into 21 groups, 2165 generic names into 825, 4387 product specifications into 1256, further focusing on the volume of bidding and increasing the price reduction chips One year, 1.5 billion yuan will be saved in the purchasing catalogue The group purchasing organization, or GPO for short, is the group purchasing organization Originated in the early 20th century in the United States, through the market competition, the demand of hospitals is centralized through procurement intermediaries The emergence of GPO has played a role in cost saving of medical institutions and reducing the pressure of rising medical costs in the United States In November 2017, the people's Government of Guangdong Province issued the notice on deepening the implementation plan of the reform of payment mode of basic medical insurance, which made it clear that medical institutions were allowed to choose to purchase drugs on the third-party drug electronic trading platform of Guangdong Province and the drug purchase platforms of Guangzhou and Shenzhen, and encouraged the three platforms to form an orderly and benign competition situation Under the GPO model, Shenzhen centralized the demand for drug procurement of public hospitals and handed it over to GPO GPO negotiated with drug companies to achieve "volume procurement" In the negotiation process, GPO flexibly formulated precise negotiation strategies through big data analysis, aimed at "one factory, one policy" for manufacturers and "one product, one policy" for related varieties, and reached the price reduction goal through negotiation At the same time, Shenzhen firstly "slimmed down" the procurement catalogue, eliminated the "pseudo innovation" of strange dosage forms and specifications, and formulated two batches of "Shenzhen public hospital drug group procurement catalogue" The first batch of catalogues (403 kinds in total) are mainly low-cost drugs, first-aid drugs and special drugs for women and children that are short of purchase in the market for a long time, and they need to be guaranteed by GPO The second batch of catalogue (643 kinds in total) mainly includes chemical drugs, biological products, Chinese patent medicines and basic infusion, covering the top 80% of drugs purchased by public hospitals in the city, with large amount of drug use and many manufacturers, which need to focus on price reduction Some analysts pointed out that the group procurement mode explored by Shenzhen reduced the negotiation and negotiation work in the pharmaceutical procurement link of hospitals, cut off the interest relationship between doctors and pharmaceutical enterprises, greatly reduced the space for power rent-seeking, and thus built a "firewall" to stop corruption in the pharmaceutical field In just over two years, Shenzhen GPO procurement model has been extended to Guangdong, Guangxi, Xinjiang, Heilongjiang and other places According to the calculation of the third-party professional institutions, in 2018, Shenzhen GPO saved a total of 1.516 billion yuan in drug procurement costs In December 2018, Guangdong Province held the "media communication meeting on the achievements of medical reform" Duan Yufei, director of the health and Family Planning Commission and Secretary of the Party group of Guangdong Province, said that Shenzhen took the lead in trying the "government guided and market-oriented" drug group procurement mode in the country The medical reform office of the State Council gave full affirmation to the GPO procurement in Shenzhen, and should accelerate the promotion of Shenzhen GPO Although, the purchase amount of drugs in Shenzhen public hospitals is not large, and it is only implemented in a small scale in some cities However, as a successful medical reform pilot experience, once the GPO model in Shenzhen is promoted nationwide, it will quickly affect the entire pharmaceutical market, and all pharmaceutical enterprises can not take it lightly In fact, GPO mode is being carried out in many parts of the country, showing the trend of multi-point flowering In July 2019, Shantou Medical Insurance Bureau issued the document "public opinions on the implementation of drug group procurement by public medical institutions in Shantou City (Draft for comments)", which made it clear that all public medical institutions in the city must participate in the drug group procurement reform, encourage non-public medical institutions to participate, encourage drug production enterprises and distribution enterprises in Shantou City to actively participate in the reform, and provide for their public medical institutions Should be medicine In the same month, the notice on implementing drug group procurement in the whole region (Draft for comments) was released in the drug group procurement working group of Guangxi Zhuang Autonomous Region, which made it clear that GPO joint procurement will be implemented from July 10 Only three days later, Guangxi pharmaceutical procurement center issued the notice on publicizing the benchmark price of some drugs in provincial linkage, which made it clear that relevant enterprises confirmed the linkage price of 1829 drugs in total If you do not confirm the low-cost drugs, you can apply for withdrawal, and the related drugs will not be able to enter the network or put on record for sale in this purchase cycle In April 2019, the office of the leading group for deepening the reform of the medical and health system of Shihezi City, the eighth division of Xinjiang issued the notice of the pilot promotion plan for the overall participation of public medical institutions of Shihezi City in the procurement reform of Shenzhen public hospital drug group, which made it clear that all medical institutions purchase drugs on the online drug procurement platform (Xinjiang Provincial Drug procurement platform and Shenzhen drug procurement platform, etc.) recognized by the city For products, the purchase amount shall not be less than 80% of the total purchase amount of drugs of the agency In April 2019, Jilin Medical Insurance Bureau issued a notice that it will carry out the drug cross regional alliance procurement pilot work It is necessary to learn from the new mode and practice of drug group procurement in Guangdong Province, especially Shenzhen City, and combine with the actual situation of Jilin Province to carry out the public medical institutions to carry out the drug cross regional alliance procurement pilot work According to incomplete statistics of the Bureau of health and knowledge, at present, some cities in Guangdong, Xinjiang, Jilin and Guangxi have carried out the mode of GPO cross regional alliance procurement, and there may be national documents in the future It is worth noting that Shenzhen and Guangzhou are also among the "4 + 7" pilot cities in this round of centralized drug procurement organized by the state, and their GPO organizations are also the carriers to promote the implementation of the volume procurement policy According to the analysis of the industry, GPO procurement mode is to centralize the procurement share of multiple hospitals to carry out procurement Based on the basic principle of market economy with large quantity and low price, enterprises and medical institutions can maximize the policy dividend According to experts in pharmacoeconomics, drug prices are generally reduced by 20% to 30% in drug bidding and purchase platforms On this basis, GPO will be cut down by another 20% to 30% In general, GPO can reduce drug prices by 24% to 40% With the increasing pressure of medical insurance fund, drug price reduction is just needed by the market GPO, as a purchase mode of exchanging quantity for price, will play an important role in drug price reduction with 4 + 7 purchase and pilot implementation all over the country In the future, more pharmaceutical enterprises will face price reduction, and the pattern of pharmaceutical industry will be overturned Source: Bureau of health and knowledge Author: Lei Gong